Press releases and news

Treating chronic pain is one of the greatest medical challenges of our time – and a field that has been waiting for real progress for decades. VERTANICAL was founded with the mission of finally opening up new, effective, and safe treatment options for precisely these patients.
With VER-01, we have reached an important milestone on this path. Here you will find our official press releases, current information, and selected media reports.
Known from
The IndependantThe GuardianOmrForbesFinancial TimesBusiness PunkTwsjThetimesSzSaReutersHandelsblattBusinessinsiderThe IndependantThe GuardianOmrForbesFinancial TimesBusiness PunkTwsjThetimesSzSaReutersHandelsblattBusinessinsider
04.12.2024
VERTANICAL Obtains GMP License for Danish Manufacturing Site
18.10.2024
VERTANICAL at the German Pain Congress in Mannheim
18.10.2024
ELEVATE Phase 3 Study: Recruitment Completed
15.07.2024
VERTANICAL Submits Application for Approval of VER-01
Trigger Post Popup Open

Contact

For questions and further information, please contact:
pr@vertanical.com
{Date Here}

{Post Title Here}

{Post Full Content Here}
Pressekontakt: